Related Experiment Video
Updated: Mar 27, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Chronic myeloid leukemia: past, present, future
Patricia Weinschenker Bollmann1, Auro Del Giglio2
1Hospital Israelita Albert Einstein - HIAE, São Paulo, SP, BR.
Targeted therapy, including imatinib and second-generation tyrosine-kinase inhibitors, has revolutionized chronic myeloid leukemia treatment. However, resistance mechanisms, like the T315I mutation, still pose challenges in eradicating the disease.
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Background:
- The Philadelphia chromosome and BCR-ABL oncogene discoveries were pivotal.
- Imatinib transformed chronic myeloid leukemia (CML) treatment and patient outcomes.
Purpose of the Study:
- To provide a comprehensive review of chronic myeloid leukemia.
- To emphasize advancements in CML treatment strategies.
Main Methods:
- Literature review of CML pathogenesis and treatment.
- Analysis of targeted therapy efficacy and resistance mechanisms.
Main Results:
- Imatinib significantly improved CML prognosis.
- Second-generation tyrosine-kinase inhibitors are effective, but T315I mutation confers resistance.
Conclusions:
- Targeted therapies have changed CML's natural history.
- Addressing resistance mechanisms, especially T315I mutation, is crucial for complete disease eradication.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Lineage Commitment
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...